Multinational drug corporations encountered with critical challenges.

Published: 2004-06-10 07:00:00

Updated: 2004-06-10 07:00:00

A sustained business growth having achieved by the foreign multinational drug corporations since the implementation of the prescribing and dispensing separation system seems to head for an unpredictable direction these day, showing a change in their company ranks along with a big influx of divers...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK